Veterinary vaccines are used for prevention of diseases that affect animals. Animal vaccination is a cost-effective solution to maintain animal health and sustainability, offering various benefits such as improved animal health & welfare of companion animals, improvement in livestock products, and prevention of transmission of diseases from animal to humans.
Request for Sample Report @ https://www.factomarketinsights.com/sample/337
Humans are largely dependent on animals, as they are the major source of milk, meat, and other dairy products. Thus, the demand for animal products also increases with rise in population, fueling the production of vaccines for attle, pigs, poultry, and sheep. The global animal vaccines market generated revenue of $7,571 in 2017, and is estimated to reach $11,885 million by 2025, registering a CAGR of 5.7% from 2018 to 2025.
The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, it is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is subsegmented into dogs, cats, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The animal vaccines market is growing at a steady pace due to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, rise in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the market growth. Moreover, rise in demand for animal vaccines has led to the emergence of multiple new vaccines However, lack of animal health awareness and possibility of adverse impact on veterinary vaccines on human and other animal health can restrain the growth for animal vaccines market. Furthermore, the advanced in vaccine products and production of animal vaccines for hybrid animals can help open new avenues for the growth of the animal vaccines market.
Browse Full Report with TOC @ https://www.factomarketinsights.com/report/337/animal-vaccines-market-amr
• The global animal vaccines market report provides an extensive analysis of the current market trends and future estimations prevailing in the market.
• The market estimations from 2018 to 2025 are based on high-end analysis of the key developments.
• The market scenario is comprehensively analyzed with respect to the product type and animal type.
• Recent developments and key manufacturers are listed and analyzed to understand the competitive market scenario.
• In-depth geographical analysis helps understand the regional market, which assists in strategic business planning.
KEY MARKET SEGMENTS
• By Product
o Attenuated Vaccines
o Inactivated Vaccines
o Subunit Vaccines
o Toxoid Vaccines
o Conjugate Vaccines
o Recombinant Vaccines
o DNA Vaccines
• By Animal Type
o Companion Animals
• By Region
o North America
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
The key players profiled in this report include the following:
• Bayer AG
• Eli Lilly and Company
• Ingelheim GmbH
• Merck & Co., Inc.
• Zoetis Inc.
• Ceva Santé Animale
• Sanofi S.A.
• Nutreco N.V.
• Virbac S.A.
The other players of the animal therapeutics and diagnostics market include (companies not profiled in the report):
PHL Associates, Inc.
Hygieia Biological Laboratories
Colorado Serum Company
Arko Laboratories, Ltd.
For any Query Contact Analyst @ https://www.factomarketinsights.com/enquiry/337